These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 6282375)
1. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Cusack NJ; Hourani SM Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375 [TBL] [Abstract][Full Text] [Related]
2. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets. Hall DA; Hourani SM Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900 [TBL] [Abstract][Full Text] [Related]
3. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate. Cusack NJ; Hourani SM Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191 [TBL] [Abstract][Full Text] [Related]
4. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets. Hall DA; Hourani SM Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Haslam RJ; Davidson MM; Desjardins JV Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136 [TBL] [Abstract][Full Text] [Related]
6. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate). Cusack NJ; Hourani SM Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270 [TBL] [Abstract][Full Text] [Related]
7. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets. Clare KA; Scrutton MC; Thompson NT Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472 [TBL] [Abstract][Full Text] [Related]
8. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase. Macfarlane DE; Mills DC; Srivastava PC Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146 [No Abstract] [Full Text] [Related]
9. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429 [TBL] [Abstract][Full Text] [Related]
10. Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate. Hall DA; Frost V; Hourani SM Biochem Pharmacol; 1994 Oct; 48(7):1319-26. PubMed ID: 7945429 [TBL] [Abstract][Full Text] [Related]
11. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834 [TBL] [Abstract][Full Text] [Related]
12. 5'-Methylthioadenosine and 2',5'-dideoxyadenosine blockade of the inhibitory effects of adenosine on ADP-induced platelet aggregation by different mechanisms. Agarwal KC; Parks RE Biochem Pharmacol; 1980 Sep; 29(18):2529-32. PubMed ID: 6968562 [No Abstract] [Full Text] [Related]
13. The role of GTP in prostaglandin E1 stimulation of adenylate cyclase in platelet membranes. Stein JM; Martin BR Biochem J; 1983 Jul; 214(1):231-4. PubMed ID: 6684425 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor). Haslam RJ; Vanderwel M J Biol Chem; 1982 Jun; 257(12):6879-85. PubMed ID: 6177688 [No Abstract] [Full Text] [Related]
15. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1. Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608 [TBL] [Abstract][Full Text] [Related]
17. Effects of several 5'-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells. Ukena D; Böhme E; Schwabe U Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):36-42. PubMed ID: 6092968 [TBL] [Abstract][Full Text] [Related]
19. Platelet adenylate cyclase and phospholipase C are affected differentially by ADP-ribosylation. Effects on thrombin-mediated responses. Banga HS; Walker RK; Winberry LK; Rittenhouse SE Biochem J; 1988 May; 252(1):297-300. PubMed ID: 3138970 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of prostaglandin E1-responsive platelet adenylate cyclase by heparin: a study of the mechanism of inhibition and its relevance to platelet aggregation. Amirrasooli H; Mac Neil S; Tomlinson S Br J Pharmacol; 1981 Jul; 73(3):639-47. PubMed ID: 7248663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]